CAMBRIDGE, MA, GC Therapeutics, Inc. (GCTx), announced its launch and completion of a $65 million Series A financing led by Cormorant Asset Management.
GC Therapeutics, Inc. (GCTx), announced its launch and completion of a $65 million Series A financing led by Cormorant Asset Management with participation from Mubadala Capital, Andreessen Horowitz (a16z) Bio + Health, Medical Excellence Capital, Cercano Management and Pear VC, bringing total capital raised by GCTx to $75 million.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
